![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: BRPF3 |
Gene summary for BRPF3 |
![]() |
Gene information | Species | Human | Gene symbol | BRPF3 | Gene ID | 27154 |
Gene name | bromodomain and PHD finger containing 3 | |
Gene Alias | BRPF3 | |
Cytomap | 6p21.31 | |
Gene Type | protein-coding | GO ID | GO:0006260 | UniProtAcc | Q9ULD4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
27154 | BRPF3 | HCC1_Meng | Human | Liver | HCC | 2.24e-39 | 6.25e-02 | 0.0246 |
27154 | BRPF3 | HCC2_Meng | Human | Liver | HCC | 5.65e-08 | 2.51e-02 | 0.0107 |
27154 | BRPF3 | HCC1 | Human | Liver | HCC | 1.04e-12 | 3.68e+00 | 0.5336 |
27154 | BRPF3 | HCC2 | Human | Liver | HCC | 3.60e-14 | 3.53e+00 | 0.5341 |
27154 | BRPF3 | S014 | Human | Liver | HCC | 3.46e-09 | 4.04e-01 | 0.2254 |
27154 | BRPF3 | S015 | Human | Liver | HCC | 5.84e-05 | 3.78e-01 | 0.2375 |
27154 | BRPF3 | S016 | Human | Liver | HCC | 1.77e-02 | 2.49e-01 | 0.2243 |
27154 | BRPF3 | S027 | Human | Liver | HCC | 1.25e-03 | 4.61e-01 | 0.2446 |
27154 | BRPF3 | S028 | Human | Liver | HCC | 4.10e-15 | 5.41e-01 | 0.2503 |
27154 | BRPF3 | S029 | Human | Liver | HCC | 8.26e-09 | 4.76e-01 | 0.2581 |
27154 | BRPF3 | male-WTA | Human | Thyroid | PTC | 1.33e-16 | 6.94e-02 | 0.1037 |
27154 | BRPF3 | PTC01 | Human | Thyroid | PTC | 2.12e-06 | -6.38e-02 | 0.1899 |
27154 | BRPF3 | PTC04 | Human | Thyroid | PTC | 7.07e-08 | 4.21e-02 | 0.1927 |
27154 | BRPF3 | PTC05 | Human | Thyroid | PTC | 7.18e-05 | 2.27e-01 | 0.2065 |
27154 | BRPF3 | PTC06 | Human | Thyroid | PTC | 4.06e-07 | 2.35e-01 | 0.2057 |
27154 | BRPF3 | PTC07 | Human | Thyroid | PTC | 5.69e-13 | 8.93e-02 | 0.2044 |
27154 | BRPF3 | ATC12 | Human | Thyroid | ATC | 7.23e-04 | -5.59e-03 | 0.34 |
27154 | BRPF3 | ATC13 | Human | Thyroid | ATC | 1.38e-37 | 7.03e-01 | 0.34 |
27154 | BRPF3 | ATC4 | Human | Thyroid | ATC | 5.71e-08 | 1.57e-02 | 0.34 |
27154 | BRPF3 | ATC5 | Human | Thyroid | ATC | 2.64e-43 | 7.72e-01 | 0.34 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001657021 | Liver | HCC | histone modification | 283/7958 | 463/18723 | 2.68e-16 | 2.33e-14 | 283 |
GO:00182052 | Liver | HCC | peptidyl-lysine modification | 230/7958 | 376/18723 | 1.51e-13 | 8.32e-12 | 230 |
GO:00064732 | Liver | HCC | protein acetylation | 135/7958 | 201/18723 | 1.20e-12 | 5.92e-11 | 135 |
GO:00435432 | Liver | HCC | protein acylation | 157/7958 | 243/18723 | 2.40e-12 | 1.12e-10 | 157 |
GO:00183942 | Liver | HCC | peptidyl-lysine acetylation | 116/7958 | 169/18723 | 5.11e-12 | 2.23e-10 | 116 |
GO:00064752 | Liver | HCC | internal protein amino acid acetylation | 107/7958 | 160/18723 | 3.77e-10 | 1.23e-08 | 107 |
GO:00183932 | Liver | HCC | internal peptidyl-lysine acetylation | 105/7958 | 158/18723 | 9.48e-10 | 2.90e-08 | 105 |
GO:00165732 | Liver | HCC | histone acetylation | 101/7958 | 152/18723 | 1.99e-09 | 5.63e-08 | 101 |
GO:00062601 | Liver | HCC | DNA replication | 146/7958 | 260/18723 | 5.68e-06 | 7.02e-05 | 146 |
GO:00062751 | Liver | HCC | regulation of DNA replication | 60/7958 | 107/18723 | 3.15e-03 | 1.46e-02 | 60 |
GO:0043966 | Liver | HCC | histone H3 acetylation | 37/7958 | 61/18723 | 3.21e-03 | 1.48e-02 | 37 |
GO:001657010 | Thyroid | PTC | histone modification | 235/5968 | 463/18723 | 1.17e-17 | 1.15e-15 | 235 |
GO:00064737 | Thyroid | PTC | protein acetylation | 116/5968 | 201/18723 | 3.05e-14 | 1.92e-12 | 116 |
GO:00435437 | Thyroid | PTC | protein acylation | 134/5968 | 243/18723 | 4.22e-14 | 2.58e-12 | 134 |
GO:00182059 | Thyroid | PTC | peptidyl-lysine modification | 188/5968 | 376/18723 | 1.34e-13 | 7.09e-12 | 188 |
GO:00183947 | Thyroid | PTC | peptidyl-lysine acetylation | 99/5968 | 169/18723 | 6.54e-13 | 3.08e-11 | 99 |
GO:00064757 | Thyroid | PTC | internal protein amino acid acetylation | 92/5968 | 160/18723 | 1.80e-11 | 7.06e-10 | 92 |
GO:00183937 | Thyroid | PTC | internal peptidyl-lysine acetylation | 91/5968 | 158/18723 | 2.04e-11 | 7.91e-10 | 91 |
GO:00165737 | Thyroid | PTC | histone acetylation | 88/5968 | 152/18723 | 2.97e-11 | 1.10e-09 | 88 |
GO:00062606 | Thyroid | PTC | DNA replication | 114/5968 | 260/18723 | 3.09e-05 | 2.95e-04 | 114 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
BRPF3 | insertion | Frame_Shift_Ins | novel | c.2554_2555insC | p.Glu855GlyfsTer9 | p.E855Gfs*9 | Q9ULD4 | protein_coding | TCGA-AX-A2HG-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
BRPF3 | insertion | Frame_Shift_Ins | novel | c.2561dupC | p.Glu855GlyfsTer9 | p.E855Gfs*9 | Q9ULD4 | protein_coding | TCGA-EO-A3KX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
BRPF3 | insertion | Frame_Shift_Ins | novel | c.2561dupC | p.Glu855GlyfsTer9 | p.E855Gfs*9 | Q9ULD4 | protein_coding | TCGA-EY-A2OM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | taxol | SD | ||
BRPF3 | SNV | Missense_Mutation | c.1061N>C | p.Gln354Pro | p.Q354P | Q9ULD4 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-CC-A7IH-01 | Liver | liver hepatocellular carcinoma | Male | <65 | III/IV | Unknown | Unknown | SD | |
BRPF3 | SNV | Missense_Mutation | c.3344C>A | p.Pro1115Gln | p.P1115Q | Q9ULD4 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-05-4396-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
BRPF3 | SNV | Missense_Mutation | c.3438G>T | p.Gln1146His | p.Q1146H | Q9ULD4 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-44-2657-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
BRPF3 | SNV | Missense_Mutation | c.854G>A | p.Gly285Glu | p.G285E | Q9ULD4 | protein_coding | deleterious(0.05) | probably_damaging(1) | TCGA-44-7667-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
BRPF3 | SNV | Missense_Mutation | rs370467092 | c.3212N>A | p.Arg1071His | p.R1071H | Q9ULD4 | protein_coding | tolerated(0.12) | benign(0) | TCGA-55-7994-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | carboplatin | CR |
BRPF3 | SNV | Missense_Mutation | c.2161C>T | p.Arg721Cys | p.R721C | Q9ULD4 | protein_coding | deleterious(0.04) | possibly_damaging(0.446) | TCGA-55-7995-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | CR | |
BRPF3 | SNV | Missense_Mutation | novel | c.990G>C | p.Gln330His | p.Q330H | Q9ULD4 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-J2-A4AD-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
27154 | BRPF3 | DRUGGABLE GENOME | 336446909 | |||
27154 | BRPF3 | DRUGGABLE GENOME | 252166774 |
Page: 1 |